Why Don’t Weight Loss Medicines Like Ozempic and Wegovy Work for Everyone?

⏱Estimated reading time: 4 min

Why Don’t Weight Loss Medicines Like Ozempic and Wegovy Affect Everyone? 🤔

Medicines such as Ozempic and Wegovy, which contain the semaglutide compound, have become leading drugs in the fight against obesity, helping regulate appetite and blood sugar levels and promoting weight loss. However, the effectiveness of these medicines varies from person to person, and researchers are currently working to understand the reasons behind these differences.

Research shows that GLP-1 receptor agonists, such as semaglutide, can reduce body weight by up to 15% when used regularly alongside lifestyle changes. But individual differences in response to these medicines indicate that there are multiple factors influencing the results.

What did the research reveal?

⚖️ The challenge of metabolic adaptation in weight loss

One factor that may explain the difference in response is what is known as metabolic adaptation or adaptive thermogenesis. This term refers to the body’s ability to reduce its calorie-burning rate more than expected after weight loss, making continued weight loss more difficult.

This adaptation lies in the fact that the body enters an “energy-saving mode,” similar to the idea of a lamp lowering its brightness to save electricity. This shift in burning mechanisms may lead to weight stability, or what is known as a weight-loss plateau, which is common for many people during their weight-loss journey.

Alongside metabolic adaptation, several other factors affect individuals’ response to medicines containing semaglutide, such as:

  • Genetic makeup
  • Metabolic pattern
  • Body composition (the proportion of fat and lean mass)
  • Lifestyle
  • Gut microbiota (microbiota)
  • Comorbidities
  • Age and sex
Why is this important for health?

🔥 The importance of understanding energy expenditure and the effect of semaglutide

Energy expenditure, meaning the difference between calories in and calories out, is one of the decisive factors in the weight-loss process. The body burns calories for vital functions such as breathing and thinking, as well as for physical activity and digestion.

With weight loss, the body’s energy expenditure naturally decreases, due to the reduction in body mass, especially fat and lean tissues that consume energy even at rest.

But researchers are still trying to understand how semaglutide medicines affect these metabolic processes, and whether the medicines alter expenditure rates at rest, after eating, or during physical activity.

🔬 Research from advanced laboratories

At the University of Alberta, researchers use an advanced technique called a whole-room indirect calorimeter, a device similar to a hotel suite equipped to measure energy expenditure accurately by monitoring all stages of activity.

Researchers are currently recruiting participants who suffer from disorders in sugar regulation, such as insulin resistance or type 2 diabetes, to follow them for 6 months while using semaglutide, with the aim of monitoring changes in body weight, body composition, and energy expenditure.

An important scientific point

🧩 Personal response and its role in developing treatments

Knowing how the body’s energy use and body composition change during and after treatment with semaglutide is an important step toward understanding individual differences in weight-loss outcomes.

This knowledge helps develop more personalized treatment strategies, which can improve the management of obesity and type 2 diabetes, in addition to enabling early identification of people who may not respond well to the current treatment.

🏃‍♀️ Lifestyle changes that complement treatment

Current evidence supports the idea that using medicines such as semaglutide requires accompanying lifestyle changes to ensure the best results in weight loss and overall body health.

This points to the importance of addressing obesity treatment on multiple levels, including medication, nutrition, and physical activity.

A deep scientific understanding of how and why all these factors affect the body’s response to treatment will undoubtedly contribute to improving outcomes for obesity patients in the future.

Source: University of Alberta website


Discover more from Mohdbali

Subscribe to get the latest posts sent to your email.

Related Articles

Stay Connected

13,909FansLike
1,700FollowersFollow
11,000SubscribersSubscribe

Latest Articles